Insights from the patient community are valuable in designing and developing medicines and treatments that positively impact the patients who need them most. By including patients in each cycle of medicines development, from early research and clinical studies to approval and use of medicines, stakeholders in healthcare can ensure that the patient voice is heard and incorporated to improve health outcomes. Join us for this panel discussion, featuring advocates with global experience, who will examine early research, clinical development, and Health Technology Assessment/Regulatory from the perspectives of the advocate and patient communities.
source
